📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. (2015)

First Author: Sami MB

Attributed to: CANNABIDIOL AS A NOVEL THERAPEUTIC AGENT FOR PATIENTS AT ULTRA HIGH-RISK OF PSYCHOSIS: AN EXPERIMENTAL MEDICINE APPROACH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.euroneuro.2015.03.011

PubMed Identifier: 26068702

Publication URI: http://europepmc.org/abstract/MED/26068702

Type: Journal Article/Review

Volume: 25

Parent Publication: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Issue: 8

ISSN: 0924-977X